Key Market Indicators
American antibiotics imports are projected to decline to approximately $740 million by 2028, down from about $780 million in 2023. This marks a year-on-year compound annual growth rate (CAGR) decrease of 1%. Since 1996, the demand for antibiotics in the U.S. has dropped by an average of 2.4% annually. In parallel, American antibiotics exports are expected to see a sharper decline. By 2028, exports are forecasted to shrink to roughly $174 million, a significant drop from around $345 million in 2023. This represents an 11% annual decrease in CAGR. Over the past decades, since 1996, the supply of antibiotics from the U.S. has plummeted by an average of 9.3% each year.
